Application 018082
- Type
- NDA
- Sponsor
- ABBVIE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DEPAKENE | VALPROIC ACID | SYRUP;ORAL | 250MG/5ML | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N018082-001 | DEPAKENE | VALPROIC ACID | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N018082-001 | DEPAKENE | 250MG/5ML | SYRUP / ORAL | RLD, Approved before 1982 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N018082-001 | DEPAKENE | 250MG/5ML | SYRUP / ORAL | RLD, Approved before 1982 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N018082-001 | DEPAKENE | 250MG/5ML | SYRUP / ORAL | RLD, Approved before 1982 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N018082-001 | DEPAKENE | 250MG/5ML | SYRUP / ORAL | RLD, Approved before 1982 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N018082-001 | DEPAKENE | 250MG/5ML | SYRUP / ORAL | RLD, Approved before 1982 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N018082-001 | DEPAKENE | 250MG/5ML | SYRUP / ORAL | RLD, Approved before 1982 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N018082-001 | DEPAKENE | 250MG/5ML | SYRUP / ORAL | RLD, Approved before 1982 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N018082-001 | DEPAKENE | 250MG/5ML | SYRUP / ORAL | RLD, Approved before 1982 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N018082-001 | DEPAKENE | 250MG/5ML | SYRUP / ORAL | RLD, Approved before 1982 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N018082-001 | DEPAKENE | 250MG/5ML | SYRUP / ORAL | RLD, Approved before 1982 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N018082-001 | DEPAKENE | 250MG/5ML | SYRUP / ORAL | RLD, Approved before 1982 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N018082-001 | DEPAKENE | 250MG/5ML | SYRUP / ORAL | AA | RLD, RS, Approved before 1982 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | N018082-001 | DEPAKENE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | RLD, Approved before 1982 | e64feba35796… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-07-19 19:46 UTC | 2019-07 | N018082-001 | AA | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VALPROIC ACID | VALPROIC ACID | American Health Packaging | 4b619f73-44e5-4a99-b425-a96cb2228c87 | 2026-08-04 | Boxed warning, Warnings, Adverse reactions | VALPROIC ACID |
| VALPROIC ACID | VALPROIC ACID | REMEDYREPACK INC. | 65c1589e-c591-4b79-b75e-884c0d609ae8 | 2026-06-08 | Boxed warning, Warnings, Adverse reactions | VALPROIC ACID |
| Valproic | VALPROIC ACID | Actavis Pharma, Inc. | cef3e335-5891-412f-89c4-79fcd2f145b7 | 2026-06-02 | Boxed warning, Warnings, Adverse reactions | VALPROIC ACID |
| Valproic Acid | VALPROIC ACID | Bionpharma Inc. | ceb52870-76d0-4108-a1d4-ba7096fbacdd | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | VALPROIC ACID |
| Valproic Acid | VALPROIC ACID | Chartwell RX, LLC | 8051ad62-3b6e-461e-8090-60f5c0a904f4 | 2026-04-27 | Boxed warning, Warnings, Adverse reactions | VALPROIC ACID |
| Valproic Acid | VALPROIC ACID | REMEDYREPACK INC. | ec41025a-ed7d-48c8-9005-08e3a9417f30 | 2026-04-23 | Boxed warning, Warnings, Adverse reactions | VALPROIC ACID |
| Valproic Acid | VALPROIC ACID | Xttrium Laboratories Inc. | 3b124a29-30bd-d30e-e063-6294a90ac4ca | 2026-04-02 | Boxed warning, Warnings, Adverse reactions | VALPROIC ACID |
| Valproic Acid | VALPROIC ACID | ANI Pharmaceuticals, Inc. | 2314af65-b928-42a9-91eb-6372909ab4f5 | 2026-03-31 | Boxed warning, Warnings, Adverse reactions | VALPROIC ACID |
| Valproic Acid | VALPROIC ACID | Chartwell Governmental & Specialty RX, LLC. | 5d19f389-7180-4e01-845f-519b7ea60ba0 | 2025-11-19 | Boxed warning, Warnings, Adverse reactions | VALPROIC ACID |
| VALPROIC ACID | VALPROIC ACID | Major Pharmaceuticals | a33f7657-ad0f-43e9-ba48-024746e6d08e | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | VALPROIC ACID |
| Valproic Acid | VALPROIC ACID | REMEDYREPACK INC. | 1edd220d-d151-4177-9a29-9fee36489fb7 | 2025-10-01 | Boxed warning, Warnings, Adverse reactions | VALPROIC ACID |
| Valproic Acid | VALPROIC ACID | Kesin Pharma Corporation | 3a2155d0-e79d-3e11-e063-6294a90a4aae | 2025-07-17 | Boxed warning, Warnings, Adverse reactions | VALPROIC ACID |
| valproic acid | VALPROIC ACID | Upsher-Smith Laboratories, LLC | 7d4df6ad-3d53-4664-9200-749487bf3689 | 2025-07-09 | Boxed warning, Warnings, Adverse reactions | VALPROIC ACID |
| Valproic Acid | VALPROIC ACID | ATLANTIC BIOLOGICALS CORP. | 453444b6-1f50-49de-ab3c-1e429c83bffa | 2025-06-27 | Boxed warning, Warnings, Adverse reactions | VALPROIC ACID |
| Valproic Acid | VALPROIC ACID | NCS HealthCare of KY, LLC dba Vangard Labs | 8785a152-3010-4370-aaf5-11315a1a56e1 | 2025-06-04 | Boxed warning, Warnings, Adverse reactions | VALPROIC ACID |
| Valproic | VALPROIC ACID | Aphena Pharma Solutions - Tennessee, LLC | 34a0d45a-4388-7d8b-e063-6394a90a6c3f | 2025-05-23 | Boxed warning, Warnings, Adverse reactions | VALPROIC ACID |
| VALPROIC ACID | VALPROIC ACID | PAI Holdings, LLC dba PAI Pharma | 7d5cb52e-37dd-4dfa-a6f4-09f9548846c6 | 2025-01-24 | Boxed warning, Warnings, Adverse reactions | VALPROIC ACID |
| Valproic Acid | VALPROIC ACID | Bryant Ranch Prepack | a9cef1ec-ba52-4849-8889-87898d6f4199 | 2025-01-24 | Boxed warning, Warnings, Adverse reactions | VALPROIC ACID |
| Valproic Acid | VALPROIC ACID | Direct_Rx | 8bdbacb1-b38a-3282-e053-2a95a90af022 | 2025-01-20 | Boxed warning, Warnings, Adverse reactions | VALPROIC ACID |
| VALPROIC ACID | VALPROIC ACID | Bryant Ranch Prepack | db53c5aa-d7a5-49ba-8227-c2d67ced23e2 | 2024-10-04 | Boxed warning, Warnings, Adverse reactions | VALPROIC ACID |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0074-5682 | Depakene | Valproic Acid | AbbVie Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 63337 | SUPPL | 2020-05-29 |
| 63158 | SUPPL | 2020-05-20 |
| 61068 | SUPPL | 2019-11-26 |
| 61057 | SUPPL | 2019-11-26 |
| 57783 | SUPPL | 2019-02-22 |
| 57761 | SUPPL | 2019-02-22 |
| 56338 | SUPPL | 2018-11-08 |
| 54086 | SUPPL | 2018-05-10 |
| 54066 | SUPPL | 2018-05-10 |
| 49999 | SUPPL | 2017-10-10 |
| 49984 | SUPPL | 2017-10-06 |
| 47508 | SUPPL | 2017-03-08 |
| 47480 | SUPPL | 2017-03-07 |
| 45841 | SUPPL | 2016-11-08 |
| 45811 | SUPPL | 2016-11-04 |
| 14030 | SUPPL | 2016-02-23 |
| 11155 | SUPPL | 2016-02-23 |
| 11154 | SUPPL | 2015-10-06 |
| 835 | SUPPL | 2015-09-25 |
| 11153 | SUPPL | 2015-03-17 |
| 834 | SUPPL | 2015-03-17 |
| 33431 | SUPPL | 2015-01-08 |
| 832 | SUPPL | 2015-01-08 |
| 33430 | SUPPL | 2014-12-03 |
| 14028 | SUPPL | 2014-11-24 |
| 11152 | SUPPL | 2014-08-22 |
| 14029 | SUPPL | 2014-08-21 |
| 33425 | SUPPL | 2014-06-23 |
| 829 | SUPPL | 2014-06-23 |
| 833 | SUPPL | 2014-06-11 |
| 11151 | SUPPL | 2014-06-10 |
| 11150 | SUPPL | 2013-09-17 |
| 831 | SUPPL | 2013-09-17 |
| 33429 | SUPPL | 2013-07-02 |
| 33428 | SUPPL | 2013-03-04 |
| 14027 | SUPPL | 2013-03-01 |
| 14026 | SUPPL | 2011-10-13 |
| 14024 | SUPPL | 2011-10-13 |
| 830 | SUPPL | 2011-10-13 |
| 828 | SUPPL | 2011-10-13 |
| 33427 | SUPPL | 2011-10-12 |
| 33426 | SUPPL | 2011-10-12 |
| 11149 | SUPPL | 2011-10-12 |
| 11148 | SUPPL | 2011-10-12 |
| 33424 | SUPPL | 2009-05-12 |
| 14025 | SUPPL | 2009-05-01 |
| 44019 | ORIG | 2008-02-01 |
| 14023 | SUPPL | 2006-10-23 |
| 33423 | SUPPL | 2006-10-18 |
| 827 | SUPPL | 2006-01-20 |
| 33422 | SUPPL | 2006-01-13 |
| 826 | SUPPL | 2004-06-02 |